Asymmetric RNA Distribution among Cells and Their Secreted Exosomes: Biomedical Meaning and Considerations on Diagnostic Applications
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Over the past few years, exosomes and their RNA cargo have been extensively studied because of the fascinating biological roles they play in cell-to-cell communication, including the signal exchange among cancer, stromal, and immune cells that lead to modifications of tumor microenvironment. RNAs, especially miRNAs stored within exosomes, seem to be among the main determinants of such signaling: their sorting into exosomes appears to be cell-specific and related to cellular physiopathology. Accordingly, the identification of exosomal miRNAs in body fluids from pathological patients has become one of the most promising activity in the field of biomarker discovery. Several analyses on the qualitative and quantitative distribution of RNAs between cells and their secreted exosomes have given rise to questions on whether and how accurately exosomal RNAs would represent the transcriptomic snapshot of the physiological and pathological status of secreting cells. Although the exact molecular mechanisms of sorting remain quite elusive, many papers have reported an evident asymmetric quantitative distribution of RNAs between source cells and their exosomes. This phenomenon could depend both on passive and active sorting mechanisms related to: (a) RNA turnover; (b) maintaining the cytoplasmic miRNA : target equilibrium; (c) removal of RNAs not critical or even detrimental for normal or diseased cells. These observations represent very critical issues in the exploitation of exosomal miRNAs as cancer biomarkers. In this review, we will discuss how much the exosomal and corresponding donor cell transcriptomes match each other, to better understand the actual reliability of exosomal RNA molecules as pathological biomarkers reflecting a diseased status of the cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanotubular Highways for Intercellular Organelle Transport
Rustom, A., Saffrich, R., Markovic, I., Walther, P., & Gerdes, H.-H. (2004) · Science · doi:10.1126/science.1093133 · Cited by 2,038
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., & Ochiya, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107821 · Cited by 1,934 · cited 1×
“The sorting of RNA molecules within mammalian cells appears to be independent of ESCRT and dependent on ceramide (Kosaka et al., 2010).”
BackgroundMicroRNA profiling: approaches and considerations
Pritchard, C. C., Cheng, H. H., & Tewari, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3198 · Cited by 1,765
Escola, J.-M., Kleijmeer, M. J., Stoorvogel, W., Griffith, J. M., Yoshie, O., & Geuze, H. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20121 · Cited by 1,228
Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
Pritchard, C. C., Kroh, E., Wood, B., Arroyo, J. D., Dougherty, K. J., Miyaji, M. M., Tait, J. F., & Tewari, M. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0370 · Cited by 879 · cited 2×
“Moreover, also the use of disparate methods to profile RNA expression from exosomes could add further bias to final data and cause a scanty reproducibility among different studies (Git et al., 2010; Chugh and Dittmer, 2012; Pritchard et al., 2012a; Moldovan et al., 2014).”
BackgroundCirculating Exosomal microRNAs as Biomarkers of Colon Cancer
Ogata-Kawata, H., Izumiya, M., Kurioka, D., Honma, Y., Yamada, Y., Furuta, K., Gunji, T., Ohta, H., Okamoto, H., Sonoda, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092921 · Cited by 809 · cited 5×
“, 2016); nevertheless, its exosomal levels in serum of CRC patients are increased (Ogata-Kawata et al., 2014).”
BackgroundInfluentialMicroRNA as Biomarkers and Diagnostics
Wang, J., Chen, J., & Sen, S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25056 · Cited by 793
Git, A., Dvinge, H., Salmon-Divon, M., Osborne, M., Kutter, C., Hadfield, J., Bertone, P., & Caldas, C. (2010) · RNA · doi:10.1261/rna.1947110 · Cited by 689
Löffler, D., Brocke-Heidrich, K., Pfeifer, G., Stocsits, C., Hackermüller, J., Kretzschmar, A. K., Burger, R., Gramatzki, M., Blumert, C., Bauer, K., et al. (2007) · Blood · doi:10.1182/blood-2007-03-081133 · Cited by 637 · cited 2×
“MiR-21 is among the most commonly upregulated miRNAs in cancer: its genetic locus at 17q23 is amplified in many solid tumors and its expression is stimulated by a variety of cancer-associated phenomena, such as inflammation and hypoxia (Griffin et al., 1988; Wu et al., 2001; Loffler et al., 2007; Fujita et al., 2008;…”
BackgroundEndogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells.
Squadrito, M. L., Baer, C., Burdet, F., Maderna, C., Gilfillan, G. D., Lyle, R., Ibberson, M., & De Palma, M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.035 · Cited by 604 · cited 5×
“Physiological or artificial overexpression of either specific miRNAs or their target mRNAs promoted a bidirectional miRNA redistribution from the cell cytoplasm/P bodies to the multivesicular bodies and, accordingly, a controlled miRNA sorting into exosomes (Squadrito et al., 2014).”
BackgroundInfluentialMethodological challenges in utilizing mi RNA s as circulating biomarkers
Moldovan, L., Batte, K. E., Trgovcich, J., Wisler, J., Marsh, C. B., & Piper, M. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12236 · Cited by 436 · cited 1×
“Moreover, also the use of disparate methods to profile RNA expression from exosomes could add further bias to final data and cause a scanty reproducibility among different studies (Git et al., 2010; Chugh and Dittmer, 2012; Pritchard et al., 2012a; Moldovan et al., 2014).”
BackgroundRibas, J., Ni, X., Haffner, M., Wentzel, E. A., Salmasi, A. H., Chowdhury, W. H., Kudrolli, T. A., Yegnasubramanian, S., Luo, J., Rodriguez, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1448 · Cited by 416
Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer
Tsukamoto, M., Iinuma, H., Yagi, T., Matsuda, K., & Hashiguchi, Y. (2017) · Oncology · doi:10.1159/000463387 · Cited by 203 · cited 2×
“Notably, several studies have reported increased levels of miR-21 in both serum and plasma exosomes from patients affected by tumors showing a cellular miR-21 upregulation (Skog et al., 2008; Taylor and Gercel-Taylor, 2008; Que et al., 2013; Ogata-Kawata et al., 2014; Hannafon et al., 2016; Lai et al., 2017; Tsukamoto…”
BackgroundYong, F. L., Law, C. W., & Wang, C. W. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-280 · Cited by 176 · cited 1×
“…of exosomal miR23a, miR-223, and miR-1246 conformed with their upregulation reported in CRC tissues and linked to their oncogenic role (Yong et al., 2013, 2014; Della Vittoria Scarpati et al., 2014; Li Z. W. et al., 2014; Zhang et al., 2014; Neerincx et al., 2015; Wang S. et al.,…”
BackgroundBinding and disruption of phospholipid bilayers by supramolecular RNA complexes
Vlassov, A., Khvorova, A., & Yarus, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141041098 · Cited by 105 · cited 1×
“It has also been reported that specific nucleotide sequences show enhanced affinity to phospholipid bilayers (Khvorova et al., 1999; Vlassov et al., 2001; Janas and Yarus, 2003; Janas et al., 2004).”
Background
Cited by
RNA delivery by extracellular vesicles in mammalian cells and its applications
O’Brien, K., Breyne, K., Ughetto, S., Laurent, L. C., & Breakefield, X. O. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0251-y · Cited by 1,811
Engineering exosomes for targeted drug delivery
Liang, Y., Duan, L., Lu, J., & Xia, J. (2021) · Theranostics · doi:10.7150/thno.52570 · Cited by 1,547
“Nucleic acids mRNAs, miRNAs, noncoding RNAs, mtDNAs [40]”
BackgroundTicket to a bubble ride: Cargo sorting into exosomes and extracellular vesicles
Anand, S., Samuel, M., Kumar, S., & Mathivanan, S. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.02.005 · Cited by 284
Exosome biogenesis, secretion and function of exosomal miRNAs in skeletal muscle myogenesis
Yue, B., Yang, H., Wang, J., Ru, W., Wu, J., Huang, Y., Lan, X., Lei, C., & Chen, H. (2020) · Cell Proliferation · doi:10.1111/cpr.12857 · Cited by 257
Caveolin-1 selectively regulates microRNA sorting into microvesicles after noxious stimuli
Lee, H., Li, C., Zhang, Y., Zhang, D., Otterbein, L. E., & Jin, Y. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20182313 · Cited by 219
Metadata
- Authors
- Ragusa, M., Barbagallo, C., Cirnigliaro, M., Battaglia, R., Brex, D., Caponnetto, A., Barbagallo, D., Di Pietro, C., & Purrello, M.
- Venue
- Frontiers in Molecular Biosciences
- Publisher
- Frontiers Media SA
- Published
- 2017-10-04
- Volume
- 4
- Pages
- 66-66
- ISSN
- 2296-889X (ISSN-L)
- OpenAlex
- W2762298343
- Cited by
- 56
- References
- 15
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.